Related Experiment Video

Updated: Aug 24, 2026

Visualization of DNA Replication in the Vertebrate Model System DT40 using the DNA Fiber Technique
07:18

Visualization of DNA Replication in the Vertebrate Model System DT40 using the DNA Fiber Technique

Published on: October 27, 2011

An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents

Waleed Abdel-Aziz1, Robert J Hickey, Linda H Malkas

  • 1Department of Medicine, Hematology/Oncology Division, Indiana University School of Medicine, Indiana University Cancer Research Institute, 1044 W. Walnut Street, R4-202 Indianapolis, IN 46202, USA. wabdelaz@iupui.edu

Biochemical Pharmacology
|June 9, 2004
PubMed

Insights

This study introduces a novel cell-free DNA replication model using the DNA synthesome to investigate anticancer drug mechanisms. The model effectively differentiates how 1-beta-d-arabinofuranosylcytosine, camptothecin, and doxorubicin impact DNA replication stages.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cancer Research

Background:

  • A novel cell-free system utilizing a purified multiprotein DNA replication complex, the DNA synthesome, has been developed.
  • The DNA synthesome is capable of orchestrating simian virus 40 (SV40) origin-specific DNA replication in vitro.
  • This system serves as a model to study anticancer agents affecting DNA replication.

Purpose of the Study:

  • To evaluate the mechanism of action of anticancer agents 1-beta-d-arabinofuranosylcytosine (ara-C), camptothecin (CPT), and doxorubicin (DOX) using the DNA synthesome model.
  • To investigate how these agents affect different stages of DNA replication.
  • To validate the DNA synthesome as an effective in vitro model for anticancer drug mechanism studies.

Main Methods:

  • Utilized a novel synthesome-based in vitro kinetic assay.
  • Isolated, characterized, and purified the DNA synthesome from mammalian cells.
  • Assessed the effects of ara-C, CPT, and DOX on SV40 origin-dependent DNA replication.

Main Results:

  • DNA replication in the synthesome model initiates at the SV40 origin and proceeds bidirectionally, mimicking in-cell processes.
  • 1-beta-d-arabinofuranosylcytosine (ara-CTP) inhibited both initiation and elongation stages.
  • Camptothecin (CPT) primarily inhibited the elongation phase, while doxorubicin (DOX) inhibited the termination stage of DNA synthesis.

Conclusions:

  • The DNA synthesome model accurately reflects in-cell DNA replication dynamics.
  • Anticancer agents ara-C, CPT, and DOX exhibit distinct mechanisms of action targeting different stages of DNA replication.
  • The DNA synthesome provides a powerful in vitro tool for dissecting anticancer agent effects on DNA replication.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Detection of DNA Breaks in Dividing Human Cells by Neutral Comet Assay05:55

Detection of DNA Breaks in Dividing Human Cells by Neutral Comet Assay

Published on: August 23, 2024

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
The DNA Replication Fork01:02

The DNA Replication Fork

An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork.   Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication forks, one in...